Key result
In adipose tissue from obese individuals, VEGF-A165b expression correlated strongly with WNT5A protein (r=0.9, P<0.001), suggesting WNT5A negatively regulates angiogenesis.
Observational (n=38)
Effect estimate: r = 0.9
p-value: p=<0.001
WNT5A negatively regulates adipose tissue angiogenesis via VEGF-A165b in human obesity, contributing to angiogenic dysfunction.
Caution against clinical targeting of adipose angiogenesis; leaves open WNT5A-VEGF-A165b validation in metabolic disease.
Experimental studies have suggested that Wingless-related integration site 5A (WNT5A) is a proinflammatory secreted protein that is associated with metabolic dysfunction in obesity. Impaired angiogenesis in fat depots has been implicated in the development of adipose tissue capillary rarefaction, hypoxia, inflammation, and metabolic dysfunction. We have recently demonstrated that impaired adipose tissue angiogenesis is associated with overexpression of antiangiogenic factor VEGF-A 165 b in human fat and the systemic circulation. In the present study, we postulated that upregulation of WNT5A is associated with angiogenic dysfunction and examined its role in regulating VEGF-A 165 b expression in human obesity. We biopsied subcutaneous and visceral adipose tissue from 38 obese individuals (body mass index: 44 ± 7 kg/m 2 , age: 37 ± 11 yr) during planned bariatric surgery and characterized depot-specific protein expression of VEGF-A 165 b and WNT5A using Western blot analysis. In both subcutaneous and visceral fat, VEGF-A 165 b expression correlated strongly with WNT5A protein ( r = 0.9, P < 0.001). In subcutaneous adipose tissue where angiogenic capacity is greater than in the visceral depot, exogenous human recombinant WNT5A increased VEGF-A 165 b expression in both whole adipose tissue and isolated vascular endothelial cell fractions ( P < 0.01 and P < 0.05, respectively). This was associated with markedly blunted angiogenic capillary sprout formation in human fat pad explants. Moreover, recombinant WNT5A increased secretion of soluble fms-like tyrosine kinase-1, a negative regulator of angiogenesis, in the sprout media ( P < 0.01). Both VEGF-A 165 b-neutralizing antibody and secreted frizzled-related protein 5, which acts as a decoy receptor for WNT5A, significantly improved capillary sprout formation and reduced soluble fms-like tyrosine kinase-1 production ( P < 0.05). We demonstrated a significant regulatory nexus between WNT5A and antiangiogenic VEGF-A 165 b in the adipose tissue of obese subjects that was linked to angiogenic dysfunction. Elevated WNT5A expression in obesity may function as a negative regulator of angiogenesis. NEW & NOTEWORTHY Wingless-related integration site 5a (WNT5A) negatively regulates adipose tissue angiogenesis via VEGF-A 165 b in human obesity.
No takes yet. Share an insight, caveat, or question.
Karki et al. (2017) conducted an observational in Obesity (n=38). WNT5A expression was evaluated on Correlation between VEGF-A165b expression and WNT5A protein in adipose tissue (r = 0.9, p=<0.001). In adipose tissue from obese individuals, VEGF-A165b expression correlated strongly with WNT5A protein (r=0.9, P<0.001), suggesting WNT5A negatively regulates angiogenesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: